Trial intelligence / Profile preview

ATX-101 for Submental Fat Reduction

NCT01032889Phase 2Completed

Sponsor
Kythera Biopharmaceuticals
Start
Dec 2009
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium deoxycholate in submental fullness, sponsored by Kythera Biopharmaceuticals. Started Dec 2009; status: completed.

02

Drugs

sodium deoxycholate
03

Conditions

submental fullness

Beyond the preview

Go deeper on NCT01032889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01032889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call